Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

This publication has 33 references indexed in Scilit:

• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
  The Lancet, 2002
• Predictors of Long‐Term Increase in CD4⁺Cell Counts in Human Immunodeficiency Virus–Infected Patients Receiving a Protease Inhibitor–Containing Antiretroviral Regimen
  The Journal of Infectious Diseases, 2002
• Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
  JAMA, 2001
• HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load
  JAMA, 2001
• Modeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996–1997
  American Journal of Epidemiology, 2001
• Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy
  Annals of Internal Medicine, 2000
• Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population
  AIDS, 2000
• CD4 cell counts at the third month of HAART may predict clinical failure
  AIDS, 1999
• HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy
  AIDS, 1999
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
  The Lancet, 1999